[{"address1": "82 Richmond Street East", "city": "Toronto", "state": "ON", "zip": "M5C 1P1", "country": "Canada", "phone": "888-846-3171", "website": "https://www.pharmather.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia and procedural sedation. It develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures. In addition, the company offers PHARMAPATCH, a microneedle patch technology solution, which includes hydrogel-forming and gelatin methacryloyl delivery system for the treatment of psychedelics and infectious diseases. Further, it has license agreement with BioRAE, Inc. for the development and commercialization of a novel biocompatible and biodegradable gelatin methacryloyl microneedle; and the University of Kansas to develop and commercialize the intellectual property of ketamine to treat ALS; as well as holds a patent and know-how license agreement with The Queen's University of Belfast to develop and commercialize hydrogel-forming microneedle patch delivery technology. The company was incorporated in 2019 and is headquartered in Toronto, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Fabio  Chianelli", "age": 46, "title": "Founder, Chairman & CEO", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 258199, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Carmelo  Marrelli ACIS, B.Comm., C.A., C.P.A., CGA, CPA", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 57500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Todd", "age": 66, "title": "Corporate Secretary", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.27, "open": 0.28, "dayLow": 0.265, "dayHigh": 0.28, "regularMarketPreviousClose": 0.27, "regularMarketOpen": 0.28, "regularMarketDayLow": 0.265, "regularMarketDayHigh": 0.28, "payoutRatio": 0.0, "volume": 6620, "regularMarketVolume": 6620, "averageVolume": 586838, "averageVolume10days": 164920, "averageDailyVolume10Day": 164920, "bid": 0.2675, "ask": 0.2784, "bidSize": 10000, "askSize": 10000, "marketCap": 24519782, "fiftyTwoWeekLow": 0.115, "fiftyTwoWeekHigh": 0.55, "allTimeHigh": 1.39, "allTimeLow": 0.037, "fiftyDayAverage": 0.30638, "twoHundredDayAverage": 0.20619, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 23352308, "profitMargins": 0.0, "floatShares": 71101169, "sharesOutstanding": 88519065, "heldPercentInsiders": 0.19271, "heldPercentInstitutions": 0.0, "impliedSharesOutstanding": 91013119, "bookValue": 0.011, "priceToBook": 25.18182, "lastFiscalYearEnd": 1748649600, "nextFiscalYearEnd": 1780185600, "mostRecentQuarter": 1748649600, "netIncomeToCommon": -1526106, "trailingEps": -0.04, "enterpriseToEbitda": -15.334, "52WeekChange": 0.31904757, "SandP52WeekChange": 0.1529237, "quoteType": "EQUITY", "currentPrice": 0.277, "recommendationKey": "none", "totalCash": 1123213, "totalCashPerShare": 0.013, "ebitda": -1522926, "totalDebt": 0, "quickRatio": 3.11, "currentRatio": 3.11, "returnOnAssets": -0.48466, "returnOnEquity": -0.922, "freeCashflow": -653390, "operatingCashflow": -1210018, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "PHRRF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "corporateActions": [], "regularMarketTime": 1758844800, "exchange": "OQB", "messageBoardId": "finmb_671235862", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "PharmaTher Holdings Ltd.", "longName": "PharmaTher Holdings Ltd.", "epsTrailingTwelveMonths": -0.04, "fiftyDayAverageChange": -0.029379994, "fiftyDayAverageChangePercent": -0.095893964, "twoHundredDayAverageChange": 0.070810005, "twoHundredDayAverageChangePercent": 0.34342113, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Newscope Capital Corporation", "nameChangeDate": "2025-09-26", "cryptoTradeable": false, "regularMarketChangePercent": 2.5925922, "regularMarketPrice": 0.277, "marketState": "CLOSED", "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1610116200000, "regularMarketChange": 0.0069999993, "regularMarketDayRange": "0.265 - 0.28", "fullExchangeName": "OTC Markets OTCQB", "averageDailyVolume3Month": 586838, "fiftyTwoWeekLowChange": 0.162, "fiftyTwoWeekLowChangePercent": 1.4086956, "fiftyTwoWeekRange": "0.115 - 0.55", "fiftyTwoWeekHighChange": -0.273, "fiftyTwoWeekHighChangePercent": -0.49636364, "fiftyTwoWeekChangePercent": 31.904757, "earningsTimestampStart": 1745524800, "earningsTimestampEnd": 1745524800, "isEarningsDateEstimate": false, "displayName": "PharmaTher", "trailingPegRatio": null, "__fetch_time": "2025-09-27"}]